Delivery Order SPE2DB22D2006-SPE2DB25FW1WW
Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $8.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $11,957.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for 4567243096 ACTIVASE 50 MG VIALS, a critical medical product, with a period of performance through February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, acting as a prime vehicle for providing a wide range of pharmaceutical products and...
- This is a $14,164.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 100 mg vials of the pharmaceutical product ACTIVASE. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and...
- This is a $3,261.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of July 10, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,784.51 Firm Fixed Price Delivery Order is for the supply of 4567602337 - ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $83,574.45 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a specialized medication, to support military healthcare programs. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,141.52 Firm Fixed Price delivery order is for the supply of ACTIVASE 100 MG VIALS, a critical medical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $8,578.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of ACTIVASE 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds...
- This federal contract award is a delivery order valued at $21,368.04 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ACTIVASE 100 MG VIALS, a medical product used to treat certain medical conditions. The contract is a firm fixed-price agreement with a performance period through November 26, 2024. This award is not associated with a set-aside program and was...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,967.98 firm fixed-price contract is for the supply of 4568791017 ACTIVASE 50 MG VIALS, a medication used in medical treatments. The contract has a performance period through July 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,935.94, is a delivery order for 4567458659 ACTIVASE 50 MG VIALS. It is a firm fixed-price contract with a completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...